Abstract:Purpose In this study, we applied laser capture microdissection and a proteomic approach to identify novel nasopharyngeal carcinoma (NPC) biomarkers. Methods Proteins from pooled microdissected NPC and normal nasopharyngeal epithelial tissues (NNET) were separated by two-dimensional gel electrophoresis, and differential proteins were identified by mass spectrometry. Expression of the differential protein cytokeratin 18 in the above two tissues as well as 4 NPC cell lines was determined by Western blotting. Immunohistochemistry was also performed to detect the expression of cytokeratin 18 in 62 cases of primary NPC, 28 cases of NNET, and 20 cases of cervical lymph node metastases, and the correlation of its expression level with clinicopathologic features and clinical outcomes were evaluated. siRNA and in vitro cell invasion assay were used to check the correlation between the expression of cytokeratin 18 and invasive ability of NPC. Results Thirty-six differential proteins between the NPC and NNET were identified. The expression level of cytokeratin 18 in the two types of tissues was confirmed by Western blotting and related to differentiation degree and metastatic potential of the NPC cell lines. Significant cytokeratin 18 down-regulation was observed in NPC versus NNET ( P = 0.000), whereas significant cytokeratin 18 up-regulation was observed in lymph node metastasis versus primary NPC ( P = 0.001). In addition, cytokeratin 18 down-regulation was significantly correlated with poor histological differentiation ( P = 0.000), whereas cytokeratin 18 up-regulation was significantly correlated with advanced clinical stage ( P = 0.019), recurrence ( P = 0.000), and regional lymph node metastasis ( P = 0.001), and distant metastasis ( P = 0.000). And down-regulated cytokeratin 18 expression by siRNA significantly decreased in vitro invasive ability of 5-8F cells. Furthermore, survival curves showed that patients with cytokeratin 18 up-regulation had a poor prognosis ( P = 0.000). Univariate analysis (Cox’s proportional hazards model) showed that WHO histologic type ( P = 0.025), lymph node metastasis ( P = 0.007), distant metastasis ( P = 0.005), recurrence ( P = 0.000), and cytokeratin 18 ( P = 0.000) were significantly associated with the prognosis of NPC. Multivariate analysis confirmed that lymph node metastasis ( P = 0.012), distant metastasis ( P = 0.009), recurrence ( P = 0.006), and cytokeratin 18 ( P = 0.001) were independent prognostic indicators. Conclusions The data suggest that cytokeratin 18 is a potential biomarker for the differentiation and prognosis of NPC, and its dysregulation might play an important role in the pathogenesis of NPC.

Comparative Proteomics Analysis of LCM Purified Nasopharyngeal Carcinoma and Normal Nasopharyngeal Epithelial Tissue

[Screening for Differentially Expressed Proteins in Nasopharyngeal Carcinoma by Laser Capture Microdissection and Proteomic Analysis].

Identification Of Novel Nasopharyngeal Carcinoma Biomarkers By Laser Capture Microdissection And Proteomic Analysis

[Differential Proteomic Analysis of Nasopharyngeal Carcinoma Cell Lines 5-8F and 6-10B].

Proteomic Analysis to Identify Cytokeratin 18 As a Novel Biomarker of Nasopharyngeal Carcinoma

Identification of metastasis-related secretory proteins in human nasopharyngeal carcinoma cells

[Establishment of Protein Expression Profile of Laser Capture Microdissection-Purified Nasopharyngeal Carcinoma Tissue].

Identification of Candidate Biomarkers for the Early Detection of Nasopharyngeal Carcinoma by Quantitative Proteomic Analysis.

Differential phosphoproteome analysis of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues

Comparative Serum Proteomic Analysis Involving Liver Organ-Specific Metastasis-Associated Proteins Of Nasopharyngeal Carcinoma

Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.

Quantitative Proteomics Analysis of LCM Purified Stroma of Nasopharyngeal Carcinoma and Normal Nasopharyngeal Mucosa

Comparative Proteome Analysis of Plasma Membrane from Different Differential Nasopharyngeal Carcinoma Cell Lines

Proteomic analysis of the stroma-related proteins in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues

Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue.

Detection of Serum Protein Biomarkers by Surface Enhancedlaser Desorption Ionization Time of Flight Mass Spectrometry in Patients of Nasopharyngeal Carcinoma

Establishment of a Specific Serum Proteomic Profile Model for Liver Organ-Specific Metastasis of Nasopharyngeal Carcinoma by Matrix-Assisted Laser Desorption/ionization Time of Flight Mass Spectrometry

iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.

Screening for Nasopharyngeal Carcinoma Antigens That Induce Humoral Immune Response by Serological Proteomics Analysis

Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis

Extensive Serum Biomarker Analysis in Patients with Nasopharyngeal Carcinoma.